
Biointron is excited to participate in Antibody Engineering & Therapeutics Europe 2025, taking place June 10-12, 2025, in Basel, Switzerland. This premier event gathers global leaders in antibody research and development to discuss the latest innovations shaping the future of therapeutics.
At the event, Biointron will showcase our advancements in antibody discovery and engineering, highlighting platforms that enhance specificity, affinity, and functionality. You are invited to visit our booth #24 to explore how our technologies accelerate therapeutic pipelines and enable precision medicine.
We look forward to engaging with researchers, industry professionals, and potential partners to exchange ideas and explore collaborations. Join Biointron at Antibody Engineering & Therapeutics Europe 2025 as we work to transform antibody therapeutics and improve patient outcomes worldwide.
For more details about the event, please visit the AET Europe 2025 website [https://informaconnect.com/antibody-engineering-europe/]
Time: June 10-12, 2025
Location: Congress Center | Basel, Switzerland
Booth: #24
Time: April 28 – 30, 2026
Location: Seoul, South Korea
Booth: #B31
Time: April 15 - 19, 2026
Location: Boston, MA
Booth: #1228
Time: May 26 - 27, 2026
Location: Taipei, Taiwan
Time: May 9 - 10, 2026
Location: Boston, MA
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.
Biointron uses cookies and similar technologies to ensure proper website functionality, understand how visitors use our website, and improve our content and services. Necessary cookies are enabled by default.
By clicking “Accept All”, you agree to the use of all cookies, including analytics and optional cookies that help us understand website usage and improve user experience. By clicking “Reject Non-Essential”, only necessary cookies will be used.
You may manage or change your cookie preferences at any time by clicking “Cookie Settings” at the bottom of the website.
For more information about how we use cookies and process personal data, please review our Privacy Policy.



